Stanley Lipkowitz
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- Ubiquitin and proteasome pathways 24
- Cell death mechanisms and regulation 18
- DNA Repair Mechanisms 7
- Oncology 42
- Cancer-related Molecular Pathways 16
- PARP inhibition in cancer therapy 13
- HER2/EGFR in Cancer Research 7
- Co-authors
- Sireesha V. Garimella (5 shared papers)Kathryn J. Chavez (2 shared papers)Marion M. Nau (11 shared papers)Seth A. Ettenberg (4 shared papers)Allan M. Weissman (1 shared paper)Maccon Keane (5 shared papers)E K Russell (1 shared paper)Hadassa Waterman (1 shared paper)
- Journals
- Cancer Research (9 papers)PLoS ONE (7 papers)Journal of Clinical Oncology (5 papers)Journal of Biological Chemistry (5 papers)Oncogene (4 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Stanley Lipkowitz
107 papers receiving 6.3k citations
Stanley Lipkowitz's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 2.2k
- Cancer Research 904
- Molecular Biology 4.0k
- Immunology 1.1k
- Cell Biology 588
Countries citing papers authored by Stanley Lipkowitz
This map shows the geographic impact of Stanley Lipkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Lipkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Lipkowitz more than expected).
Fields of papers citing papers by Stanley Lipkowitz
This network shows the impact of papers produced by Stanley Lipkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Lipkowitz. The network helps show where Stanley Lipkowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanley Lipkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1 Hit paper breakdown → | 1999 | 825 |
| 2 | Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer Hit paper breakdown → | 2011 | 583 |
| 3 | Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. | 1999 | 482 |
| 4 | 2011 | 311 | |
| 5 | 2017 | 204 | |
| 6 | 2016 | 190 | |
| 7 | 2000 | 183 | |
| 8 | 2018 | 166 | |
| 9 | 2020 | 157 | |
| 10 | Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. | 1995 | 156 |
| 11 | 2008 | 147 | |
| 12 | 1992 | 125 | |
| 13 | 1997 | 124 | |
| 14 | 1990 | 112 | |
| 15 | 2006 | 108 | |
| 16 | 2002 | 104 | |
| 17 | 2007 | 99 | |
| 18 | 2010 | 93 | |
| 19 | 2019 | 92 | |
| 20 | 2018 | 92 |
About Stanley Lipkowitz
Stanley Lipkowitz is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pathology and Forensic Medicine, having authored 111 papers that have together received 6.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (24 papers), Cell death mechanisms and regulation (18 papers), Cancer-related Molecular Pathways (16 papers), PARP inhibition in cancer therapy (13 papers), DNA Repair Mechanisms (7 papers), Ovarian cancer diagnosis and treatment (7 papers), HER2/EGFR in Cancer Research (7 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (904 citations), Molecular Biology (4.0k citations), Immunology (1.1k citations) and Cell Biology (588 citations). Stanley Lipkowitz has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Sireesha V. Garimella, Kathryn J. Chavez, Marion M. Nau, Seth A. Ettenberg, Allan M. Weissman, Maccon Keane, E K Russell, Hadassa Waterman, Alexander Y. Tsygankov and Ilan R. Kirsch. Their work appears in journals such as Cancer Research, PLoS ONE, Journal of Clinical Oncology, Journal of Biological Chemistry and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.